The Indian healthcare and pharmaceutical landscape is heading for a marked performance divergence, says Amey Chalke, Pharma Research Analyst at JM Financial. In an interview with ET Now, Chalke said the sector is witnessing strong traction in hospitals and CDMOs, while large generic pharma companies may face earnings pressure from FY27 onwards. Tariff concerns are […]
